I'm with you, Hittman! I'll keep topping up my holdings whenever funds allow it.
WBT, IMU and BRN all share the key ingredients I look for in a company:
- Smart, highly credential people with well-established reputations based on prior relevant positions.
- A growing body of unique IP with extensive, thorough patent protection.
- A strong financial position that will enable them to achieve their immediate targets.
- An established lead over their potential competitors that guarantees a good head-start.
- The ability to commercialise their product(s) and establish them in the relevant markets.
- High ethical standards that are obvious, both to shareholders and to others in their industry.
The leaders of these three companies - people like Coby Hanoch, Dadi Perlmutter, Leslie Chong, Paul Hopper, Peter van de Made, Tony Dawe, etc - are so respected within their industries that you know the companies they work for will be completely above board and that, as a shareholder, you can trust what they tell you. Their companies may not always turn into unicorns, but you know they'll give it their best shot.
IMU has so many potential drugs, either in the clinic or ready to go, that it's just a matter of waiting patiently while they work away in the clinics until the inevitable success is proven. For all those who will be given another chance at life by these drugs, that day can't come too soon!
Jeff